Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by wofatson Jul 17, 2021 1:23pm
160 Views
Post# 33565293

RE:1.3mm shares traded is a definite encouraging sign

RE:1.3mm shares traded is a definite encouraging signAn additional 1,000,000 shares traded at alternate exchanges   2,166,300 total traded yesterday.
The 661,000 shares at the Chi-X may have been an institutional cross. There has been some large trades on this exchange over the last 6 months.
Increasing share volume on exchanges that are not the TSX is interesting . 

Last year for this quarter EPS was .13  The forcast was for -02

The analyst forcast for this quarter this year is -.07   Odd?

Earnings report is out soon .
They have beat earnings for 4 quarters in a row.The EPS ,full year, is .37
They need a catalyst and they need more analyst coverage.






<< Previous
Bullboard Posts
Next >>